
Sign up to save your podcasts
Or


Send us Fan Mail
Join Dr. Urban A. Kiernan as he decodes the complex business of science, focusing on the recent legal battles and market dynamics surrounding GLP-1 medications. This episode dives deep into the dispute between Novo Nordisk and Hims & Hers over patented drugs like Wegovy and Ozempic, and the implications for compounded versions. Learn how intellectual property protection shapes the pharmaceutical landscape, influences drug accessibility, and impacts consumer costs. Dr. Kiernan explains the intricacies of drug development, legal challenges, and the evolving market for innovative therapies, empowering you with crucial insights into the health industry.
What You'll Learn:
Stay informed about the evolving world of health and medicine! #DecodingHealth #BusinessOfScience #GLP1 #PharmaLaw #DrugDevelopment
Are you eager to explore more about health and wellness? Discover an all natural solution to combating the GLP-1 Receptor Agonist craze. Click on the link below and explore the Feel Great System - a clinically proven approach to boosting natural GLP-1 production, suppressing appetite and improving both your metabolism and weight.
https://ufeelgreat.com/usa/en/c/LiveFree
As a Decoding Health viewer, you get wholesale pricing and a money back guarantee. Give it a try and let us know your results.
https://imbiopharma.com/
https://www.linkedin.com/in/urban-a-kiernan-ph-d-8568b621/
https://www.youtube.com/@DecodingHealthPodcast
Thank you to our sponsor - iMetabolic Biopharma Corporation: Together, we can be the next stage in developing a revolutionary approach to drug discovery. We give communities the opportunity to invest in their own health as we improve how drugs are discovered to make them more effective and affordable. Visit https://imbiopharma.com/ to learn more.
This show is proudly produced at PS Studios — learn more https://www.psstudios.co
By Dr. Urban A. Kiernan5
33 ratings
Send us Fan Mail
Join Dr. Urban A. Kiernan as he decodes the complex business of science, focusing on the recent legal battles and market dynamics surrounding GLP-1 medications. This episode dives deep into the dispute between Novo Nordisk and Hims & Hers over patented drugs like Wegovy and Ozempic, and the implications for compounded versions. Learn how intellectual property protection shapes the pharmaceutical landscape, influences drug accessibility, and impacts consumer costs. Dr. Kiernan explains the intricacies of drug development, legal challenges, and the evolving market for innovative therapies, empowering you with crucial insights into the health industry.
What You'll Learn:
Stay informed about the evolving world of health and medicine! #DecodingHealth #BusinessOfScience #GLP1 #PharmaLaw #DrugDevelopment
Are you eager to explore more about health and wellness? Discover an all natural solution to combating the GLP-1 Receptor Agonist craze. Click on the link below and explore the Feel Great System - a clinically proven approach to boosting natural GLP-1 production, suppressing appetite and improving both your metabolism and weight.
https://ufeelgreat.com/usa/en/c/LiveFree
As a Decoding Health viewer, you get wholesale pricing and a money back guarantee. Give it a try and let us know your results.
https://imbiopharma.com/
https://www.linkedin.com/in/urban-a-kiernan-ph-d-8568b621/
https://www.youtube.com/@DecodingHealthPodcast
Thank you to our sponsor - iMetabolic Biopharma Corporation: Together, we can be the next stage in developing a revolutionary approach to drug discovery. We give communities the opportunity to invest in their own health as we improve how drugs are discovered to make them more effective and affordable. Visit https://imbiopharma.com/ to learn more.
This show is proudly produced at PS Studios — learn more https://www.psstudios.co

365 Listeners

3,823 Listeners

7,205 Listeners

9,251 Listeners

2,567 Listeners

1,121 Listeners

132 Listeners

14,713 Listeners

521 Listeners

29,303 Listeners

518 Listeners

1,300 Listeners

355 Listeners

3,095 Listeners

80 Listeners